X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1857) 1857
Publication (161) 161
Conference Proceeding (87) 87
Patent (24) 24
Book Chapter (18) 18
Book Review (11) 11
Paper (4) 4
Book / eBook (3) 3
Dissertation (3) 3
Newspaper Article (3) 3
Report (1) 1
Trade Publication Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (670) 670
male (444) 444
female (392) 392
index medicus (369) 369
middle aged (255) 255
adult (234) 234
aged (189) 189
respiratory system (138) 138
animals (136) 136
cardiac & cardiovascular systems (118) 118
adolescent (111) 111
physics (103) 103
child (95) 95
analysis (87) 87
heart failure (78) 78
inflammation (72) 72
oxidative stress (72) 72
toxicology (72) 72
rats (71) 71
biochemistry & molecular biology (69) 69
prognosis (69) 69
treatment outcome (69) 69
hematology (67) 67
nuclear experiment (67) 67
time factors (65) 65
mortality (64) 64
research (64) 64
iron (63) 63
follow-up studies (62) 62
risk factors (62) 62
disease (61) 61
physics, nuclear (61) 61
air pollution (60) 60
iron - metabolism (53) 53
particulate matter (53) 53
echocardiography (51) 51
expression (51) 51
oncology (51) 51
transplantation (51) 51
cells, cultured (50) 50
ferritin (48) 48
immunology (48) 48
prospective studies (48) 48
cells (47) 47
health aspects (47) 47
physics, particles & fields (46) 46
physiology (46) 46
survival (46) 46
retrospective studies (45) 45
aged, 80 and over (44) 44
lungs (43) 43
children (42) 42
life sciences (42) 42
lung - metabolism (42) 42
pulmonary hypertension (42) 42
young adult (42) 42
child, preschool (41) 41
diagnosis (40) 40
abridged index medicus (39) 39
cell biology (39) 39
lung - drug effects (39) 39
care and treatment (38) 38
heart failure - physiopathology (38) 38
physiological aspects (38) 38
mice (37) 37
rats, sprague-dawley (37) 37
bronchoalveolar lavage fluid - chemistry (36) 36
chemistry, physical (36) 36
italy (35) 35
pediatrics (35) 35
severity of illness index (35) 35
therapy (35) 35
lung (34) 34
surgery (34) 34
cardiovascular (33) 33
air pollutants - toxicity (32) 32
apoptosis (32) 32
article (32) 32
hypertension (32) 32
experiment (31) 31
dose-response relationship, drug (30) 30
macrophages (30) 30
pharmacology & pharmacy (30) 30
cardiac resynchronization therapy (29) 29
cell line (29) 29
epithelial cells - drug effects (29) 29
lung - pathology (29) 29
neurosciences (29) 29
risk (29) 29
stroke volume (29) 29
epithelial cells - metabolism (28) 28
exposure (28) 28
kidney transplantation (28) 28
medicine & public health (28) 28
nuclear theory (28) 28
urology & nephrology (28) 28
air-pollution (27) 27
high energy physics (27) 27
proteins (27) 27
studies (27) 27
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1728) 1728
French (100) 100
Italian (87) 87
Spanish (10) 10
Portuguese (6) 6
Chinese (3) 3
German (3) 3
Czech (1) 1
Dutch (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Nature Communications, ISSN 2041-1723, 12/2018, Volume 9, Issue 1, pp. 1416 - 16
Pulmonary arterial hypertension (PAH) is a rare disorder with a poor prognosis. Deleterious variation within components of the transforming growth factor-beta... 
SOX17 | GENE | ANGIOGENESIS | CRYSTAL-STRUCTURE | MULTIDISCIPLINARY SCIENCES | BMP9 | ASSOCIATION | EXPRESSION | NONSENSE MUTATION | BETA-RECEPTOR | CAVEOLIN-1 | Prognosis | Humans | Male | Familial Primary Pulmonary Hypertension - diagnosis | SOXF Transcription Factors - metabolism | Aquaporin 1 - metabolism | Case-Control Studies | Familial Primary Pulmonary Hypertension - metabolism | Membrane Transport Proteins - genetics | Base Sequence | HEK293 Cells | Adult | Female | Growth Differentiation Factors - genetics | Membrane Transport Proteins - metabolism | Familial Primary Pulmonary Hypertension - pathology | Genetic Predisposition to Disease | Bone Morphogenetic Protein Receptors, Type II - genetics | Signal Transduction | Gene Expression Regulation | Adenosine Triphosphatases - metabolism | Models, Molecular | Familial Primary Pulmonary Hypertension - genetics | Bone Morphogenetic Protein Receptors, Type II - metabolism | Membrane Transport Proteins - chemistry | Whole Genome Sequencing | Aquaporin 1 - chemistry | Aquaporin 1 - genetics | Growth Differentiation Factors - metabolism | Transforming Growth Factor beta - genetics | Adenosine Triphosphatases - chemistry | Adenosine Triphosphatases - genetics | Mutation | SOXF Transcription Factors - genetics | Transforming Growth Factor beta - metabolism | SOXF Transcription Factors - chemistry | Growth Differentiation Factors - chemistry | Hypertension | Bone morphogenetic protein receptor type II | Secretion | Transforming growth factor | Genes | Genomes | Heritability | Aquaporin 1 | Gene sequencing
Journal Article
by Gerstein, Hertzel C and Bosch, Jackie and Dagenais, Gilles R and Díaz, Rafael and Jung, Hyejung and Maggioni, Aldo P and Pogue, Janice and Probstfield, Jeffrey and Ramachandran, Ambady and Riddle, Matthew C and Rydén, Lars E and Yusuf, Salim and Richardson, L and Diaz, R and Johnston, P and Vige, R and Birkeland, K and Budaj, A and Cardona, E and Chazova, I and Commerford, P and Danilova, L and Davies, M and Fernando, R and Fodor, G and Gilbert, R and Gomis, R and Hâncu, N and Hanefeld, M and Hildebrandt, P and Kacerovsky-Bielesz, G and Keltai, M and Kim, J.H and Krum, H and Kültürsay, H and Lanas, F and Lewis, B.S and Lonn, E and López-Jaramillo, P and Marin-Neto, J and Marre, M and McKelvie, R and McQueen, M and Mendoza, I and Morillo, C and Pan, C and Pīrāgs, V and Profozic, V and Ratner, R and Richardson, L and Rosenstock, J and Spinas, G.A and Sreenan, S and Stoel, I and Syvänne, M and Yale, J.F and Avezum, A and Bahit, M.C and Bogaty, P and Bordeleau, L and Chacόn, C and Corson, M and Harper, W.L and Halon, D and Magloire, P and Mann, J and Pavlova, V and Punthakee, Z and Silva, J and Tsang, B and Yakubovich, N and Abdallah, A and Ahmad, S and Chandra, J and Chandra, R and Cukierman-Yaffee, T and Dyal, L and Joldersma, L and MacRae, L and MacRae, S and Malik, S and Mead, A and Pasha, F and Pazmino-Canizares, J and Pohl, K and Sakalas, A and Tyrwhitt, J and Ahuad Guerrero, R and Alebuena, A and Alvarez, N and Alzogaray, M and Amuchastegui, M and Andres, M and Angos, M and Baglivo, H and Barbieri, M and Bassi, F and Bello, F and Bono, J and Bustamante Labarta, M and ... and The ORIGIN Trial Investigators and ORIGIN Trial Investigators and Medicinska och farmaceutiska vetenskapsområdet and Uppsala universitet and Medicinska och farmaceutiska vetenskapsområdet, centrumbildningar mm and Centrum för klinisk forskning, Västerås
The New England Journal of Medicine, ISSN 0028-4793, 07/2012, Volume 367, Issue 4, pp. 319 - 328
In this study with a 2-by-2 factorial design, patients with cardiovascular risk factors and dysglycemia or type 2 diabetes received insulin glargine or... 
DIABETES-MELLITUS | MEDICINE, GENERAL & INTERNAL | GLYCEMIC CONTROL | THERAPY | GLARGINE | GLUCOSE CONTROL | DISEASE | RISK | PEOPLE | ENDOTHELIAL FUNCTION | BETA-CELL FUNCTION | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Cholesterol - blood | Humans | Middle Aged | Male | Incidence | Glucose Intolerance - drug therapy | Cardiovascular Diseases - epidemiology | Female | Drug Therapy, Combination | Hypoglycemia - chemically induced | Diabetes Mellitus, Type 2 - complications | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - etiology | Fasting | Blood Glucose - analysis | Double-Blind Method | Proportional Hazards Models | Hospitalization | Glucose Intolerance - complications | Insulin, Long-Acting - adverse effects | Insulin Glargine | Insulin, Long-Acting - therapeutic use | Intention to Treat Analysis | Triglycerides - blood | Fatty Acids, Omega-3 - therapeutic use | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Type 2 diabetes | Complications and side effects | Care and treatment | Insulin glargine | Patient outcomes | Causes of | Cardiovascular diseases | Risk factors | Myocardial infarction | Fees & charges | Cerebral infarction | Medical research | Stroke | Heart attacks | Statistical analysis | Diabetes mellitus | Glucose | Hypoglycemia | Fatty acids | Insulin | Glucose tolerance | Insulin resistance | Microvasculature | Diabetes | Diabetes mellitus (non-insulin dependent) | Heart diseases | Drug dosages | Cardiovascular Diseases | Insulin, Long-Acting | Blood Glucose | Triglycerides | Glucose Intolerance | Cholesterol | Life Sciences | Hypoglycemic Agents | Diabetes Mellitus, Type 2 | Fatty Acids, Omega-3 | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article